Prof. Dr. med. Wolfgang Harms

• Appius H, Hafer J, Harms W, Bolli M, Buess: Reproducibility of the CROSS-Trial Results in the Multimodal Treatment of Esophageal Cancer in Daily Practice: A Single Center Retrospective Observational Study. M. J Oncol. 8955720. 
• Appius H, Hafer J, Harms W, Bolli M, Buess: Reproducibility of the CROSS-Trial Results in the Multimodal Treatment of Esophageal Cancer in Daily Practice: A Single Center Retrospective Observational Study. M. J Oncol. 8955720.
• Krug D, Baumann R, Combs SE, Duma MN, Dunst J, Feyer P, Fietkau R, Haase W, Harms W, Hehr T, Piroth MD, Sedlmayer F, Souchon R, Strnad V, Budach W: Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO). 33 Moderate hypofractionation remains the standard of care for whole-breast radiotherapy in breast cancer: Considerations regarding FAST and FAST-Forward. 2021: Strahlenther Onkol. 197(4): 269–280.
• Piroth MD, Krug D, Sedlmayer F, Duma MN, Baumann R, Budach W, Dunst J, Feyer P, Fietkau R, Haase W, Harms W, Hehr T, Souchon R, Strnad V, Sauer R: Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO). Post-neoadjuvant treatment with capecitabine and trastuzumab emtansine in breast cancer patients – sequentially, or better simultaneously? 2021: Strahlenther Onkol. 197(1): 1–7.
• Asadpour B, Harms W: Totale neoadjuvante Radiochemotherapie (TNT) ermöglicht Organerhalt. 2021: Schweizer Zeitschrift für Onkologie 5: 12–16.
• Strnad V, Krug D, Sedlmayer F, Piroth MD, Budach W, Baumann R, Feyer P, Duma MN, Haase W, Harms W, Hehr T, Fietkau R, Dunst J, Sauer R; Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO). DEGRO practical guideline for partial-breast irradiation. Strahlenther Onkol. 2020 Sep;196(9):749-763. doi: 10.1007/s00066-020-01613-z. Epub 2020 Apr 29. PMID: 32350554; PMCID: PMC7449998.
• Krug D, Baumann R, Budach W, Duma MN, Dunst J, Feyer P, Fietkau R, Haase W, Harms W, Hehr T, Piroth MD, Sedlmayer F, Souchon R, Wenz F, Sauer R. Commercially Available Gene Expression Assays as Predictive Tools for Adjuvant Radiotherapy? A Critical Review. Breast Care (Basel). 2020 Apr;15(2):118-126. doi: 10.1159/000505656. Epub 2020 Jan 24. PMID: 32398980; PMCID: PMC7204850.
• Harms W, Asadpour B, Mosna-Firlejczyk K, Neppach K, Cescato-Wenger C, Siebert M, Zanetti Dällenbach R. Radiotherapie des Mammakarzinoms: langes, kurzes und ultrakurzes Protokoll. Leading Opinions Hämatologie und Onkologie 07/2020
• Piroth MD, Baumann R, Budach W, Dunst J, Feyer P, Fietkau R, Haase W, Harms W, Hehr T, Krug D, Röser A, Sedlmayer F, Souchon R, Wenz F, Sauer R; Heart toxicity from breast cancer radiotherapy: Current findings, assessment, and prevention. Strahlenther Onkol. 2019 Jan; 195(1): 1–12. Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO).
• Duma MN, Baumann R, Budach W, Dunst J, Feyer P, Fietkau R, Haase W, Harms W, Hehr T, Krug D, Piroth MD, Sedlmayer F, Souchon R, Sauer R; Heart-sparing radiotherapy techniques in breast cancer patients: a recommendation of the breast cancer expert panel of the German society of radiation oncology (DEGRO).  Strahlenther Onkol. 2019 Oct; 195(10): 861–871.
• Hehr T, Baumann R, Budach W, Duma MN, Dunst J, Feyer P, Fietkau R, Haase W, Harms W, Krug D, Piroth MD, Sedlmayer F, Souchon R, Wenz F, Sauer R; Radiotherapy after skin-sparing mastectomy with immediate breast reconstruction in intermediate-risk breast cancer: Indication and technical considerations. Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO). Strahlenther Onkol. 2019 Nov; 195(11): 949–963.
• Piroth MD, Baumann R, Budach W, Dunst J, Feyer P, Fietkau R, Haase W, Harms W, Hehr T, Krug D, Röser A, Sedlmayer F, Souchon R, Wenz F, Sauer R. Heart toxicity from breast cancer radiotherapy: Current findings, assessment, and prevention. Strahlenther Onkol. 2018 Oct 11.
• Krug D, Baumann R, Budach W, Dunst J, Feyer P, Fietkau R, Haase W, Harms W, Hehr T, Piroth MD, Sedlmayer F, Souchon R, Wenz F, Sauer R. Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO). Neoadjuvant chemotherapy for breast cancer-background for the indication of locoregional treatment. Strahlenther Onkol. 2018 Sep; 194(9): 797–805.
• Krug D, Baumann R, Budach W, Dunst J, Feyer P, Fietkau R, Haase W, Harms W, Hehr T, Piroth MD, Sedlmayer F, Souchon R, Wenz F, Sauer R. Individualization of post-mastectomy radiotherapy and regional nodal irradiation based on treatment response after neoadjuvant chemotherapy for breast cancer: A systematic review. Strahlenther Onkol. 2018 Jul; 194(7): 607–618.

• Grosser K., Schulte A., Harms W.: An Electronically Configurable Checklist Program for Quality Control of RT Treatment Planning. Radiotherapy and Oncology; Volume 123, Supplement 1, 2017 May; S563

• Herraiz Lablanca M., Paul S., Chiesa M., Grosser K., W. Harms: Evaluation of an Auto-segmentation Software for Definition of Organs at Risk in Radiotherapy. Radiotherapy and Oncology; Volume 123, Supplement 1, 2017 May; S554
• Krug D., Baumann R., Budach W., Dunst J., Feyer P., Fietkau R., Haase W., Harms W., Piroth M., Sautter-Bihl M., Sedlmayer F., Souchon R., Wenz F., Sauer R.; Breast cancer expert panel of the German Society of Radiation Oncology (DEGRO): Current Controversies in Radiotherapy for Breast Cancer. Radiat Oncol. 2017 Jan 23; 12(1): 25
• Harms, W., Budach, W., Dunst, J. et al.: DEGRO practical guidelines for radiotherapy of breast cancer VI: therapy of locoregional breast cancer recurrences. Strahlenther Onkol 2016: 192: 199–208
• Harms W., Geretschläger A., Cescato C., Buess M., Köberle D., Asadpour B.: Current Treatment of Isolated Locoregional Breast Cancer Recurrences. Breast Care (Basel). Aug 2015: 10(4): 265–71
• Asadpour B., Harms W.: Von der adjuvanten zur neoadjuvanten Radio-/Radiochemotherapie: Multimodale Therapie des Rektumkarzinoms. InFo Onkologie & Hämatologie. 2015: 8: 1–6
• Budach W., Matuschek C., Bölke E., Dunst J., Feyer P., Fietkau R., Haase W., Harms W., Piroth M.D., Sautter-Bihl M.L., Sedlmayer F., Souchon R., Wenz F., Sauer R.: Breast Cancer Expert Panel of German Society of Radiation Oncology (DEGRO). DEGRO practical guidelines for radiotherapy of breast cancer V: Therapy for locally advanced and inflammatory breast cancer, as well as local therapy in cases with synchronous distant metastases. Strahlenther Onkol 2015: 191: 623–33
• Rochet N., Lindel K., Katayama S., Schubert K., Herfarth K., Schneeweiss A., Sohn C., Harms W., Debus J.: Intensity-modulated whole abdomen irradiation following adjuvant carboplatin/taxane chemotherapy for FIGO stage III ovarian cancer: four-year outcomes. Strahlenther Onkol. 2015: 191: 582–9
• Sautter-Bihl M.L., Sedlmayer F., Budach W., Dunst J., Feyer P., Fietkau R., Haase W., Harms W., Piroth M. D., Souchon R., Wenz F., Sauer R. - Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO): How nescience may obscure evidence. Strahlenther. Onkol. Oct 2014: 190(10): 861-3.
• Rochet N, Sterzing F, Jensen A, Dinkel J, Herfarth K, Schubert K, Eichbaum M, Schneeweiss A, Sohn C, Debus J, Harms W.: intensity-modulated whole-abdominal radiotherapy after surgery and carboplatin/taxane chemotherapy for advanced ovarian cancer: phase I study. Int J Radiat Oncol Biol Phys 2009 in press.
• Hauswald H, Rochet N, Becker H, Stoiber E, Debus J, Harms W.: Treatment of Recurrent Bronchial Carcinoma: The Role of High-Dose-Rate Endoluminal Brachytherapy (HDREB). Int J Radiat Oncol Biol Phys 2009 in press.
• Sautter-Bihl ML, Souchon R, Budach W, Sedlmayer F, Feyer P, Harms W, Haase W, Dunst J, Wenz F, Sauer R.: DEGRO practical guidelines for radiotherapy of breast cancer II. Postmastectomy radiotherapy, irradiation of regional lymphatics, and treatment of locally advanced disease. Strahlenther Onkol 2008;184:347-53.
• Krempien R, Hoppe H, Kahrs L, Daeuber S, Schorr O, Eggers G, Bischof M, Munter MW, Debus J, Harms W.: Projector-Based Augmented Reality for Intuitive Intraoperative Guidance in Image-Guided 3D Interstitial Brachytherapy. Int J Radiat Oncol Biol Phys 2008;70:944-52.
• Hauswald H, Lindel K, Rochet N, Debus J, Harms W.: Surgery with Complete Resection Improves Survival in Radiooncologically Treated Patients with Cervical Lymph Node Metastases from Cancer of Unknown Primary. Strahlenther Onkol 2008;184:150-156.
• Rochet N, Sterzing F, Jensen A, Dinkel J, Herfarth K, Schubert K, Eichbaum M, Schneeweiss A, Sohn C, Debus J, Harms W.: Helical Tomotherapy as a New Treatment Technique for Whole Abdominal Irradiation. Strahlenther Onkol 2008;184:145-149.
• Roeder F, Treiber M, Oertel S, Dinkel J, Timke C, Funk A, Garcia-Huttenlocher H, Bischof M, Weitz J, Harms W, Hensley FW, Buchler MW, Debus J, Krempien R.: Patterns of failure and local control after intraoperative electron boost radiotherapy to the presacral space in combination with total mesorectal excision in patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2007;67:1381-8.
• Sauer R, Sautter-Bihl ML, Budach W, Feyer P, Harms W, Souchan R, Wallwiener D, Kreienberg R, Wenz F.: Accelerated partial breast irradiation: consensus statement of 3 German Oncology societies. Cancer 2007;110:1187-94.
• Schöffel PJ, Harms W, Sroka-Perez G, Schlegel W, Karger CP.: Accuracy of a commercial optical 3D surface imaging system for realignment of patients for radiotherapy of the thorax. Phys Med Biol 2007;52:3949-63.
• Sterzing F, Grehn C, Dinkel J, Krempien R, Hartung G, Debus J, Harms W.: Severe reversible toxic encephalopathy induced by cisplatin in a patient with cervical carcinoma receiving combined radiochemotherapy. Strahlenther Onkol 2007;183:487-9.
• Sautter-Bihl ML, Budach W, Dunst J, Feyer P, Haase W, Harms W, Sedlmayer F, Souchon R, Wenz F, Sauer R.: DEGRO Practical Guidelines for Radiotherapy of Breast Cancer I: Breast-Conserving Therapy. Strahlenther Onkol. 2007;183:661-6.
• Rochet N, Jensen AD, Sterzing F, Munter MW, Eichbaum MH, Schneeweiss A, Sohn C, Debus J, Harms W.: Adjuvant whole abdominal intensity modulated radiotherapy (IMRT) for high risk stage FIGO III patients with ovarian cancer (OVAR-IMRT-01) - Pilot trial of a phase I/II study: study protocol. BMC Cancer 2007;7:227.
• Harms W.: Strahlentherapie im Alter. Geriatrie Praxis 2007;4:8-12.
• Eichbaum M, Harms W, Bolz S, Schneeweiss A, Sohn C.: Generalized lichen ruber planus with oral manifestation – induced by radiotherapy of the breast? Onkologie 2006;29:521-3.
• Krempien R, Münter MW, Harms W, Debus J.: Neoadjuvant chemoradiation in patients with pancreatic adenocarcinoma. HPB 2006;8:22-28.
• Leitlinien in der Radioonkologie, Radiotherapie des Mammakarzinoms, Koordinator R. Sauer, Organgruppe Mammakarzinom der DEGRO, Expertengruppe: Budach W, Dunst J, Feyer P, Haase W, Harms W, Sautter-Bihl ML, Souchon R, Wenz F, Strahlenther Onkol 2006;182:Supplemet I, Seite 1-29.
• Harms W, Krempien R, Grehn C, Hensley F, Debus J, Becker HD.: Electromagnetically navigated brachytherapy as a new treatment option for peripheral pulmonary tumors. Strahlenther Onkol 2006;182:108-11.
• Krempien RC, Röder F, Oertel S, Weitz J, Hensley FW, Timke C, Funk A, Lindel K, Harms W, Buchler MW, Debus J, Treiber M.: Intraoperative Electron Beam Therapy (IOERT) for primary and recurrent retroperitoneal soft tissue sarcoma. Int J Radiat Oncol Biol Phys 2006;65:773-9.
• Harms W, Weber KJ, Ehemann V, Zuna I, Debus J, Peschke P.: Differential effects of CLDR and PDR brachytherapy on cell cycle progression in a syngeneic rat prostate tumour model. Int J Radiat Biol 2006;82:191-6.
• Eichbaum M, Schneeweiss A, Harms W, Schemmer P, Sohn C.: Ileouterine fistula: a rare complication after primary treatment of advanced endometrial cancer. Lancet Oncology 2006;7:442.
• Souchon R, Budach W, Dunst J, Feyer P, Haase W, Harms W, Sautter Bihl M-L, Wenz F, Sauer R.: Auf eine Radiotherapie nach brusterhaltender Operation eines ductalen Carcinoma in situ (DCIS) darf nicht verzichtet werden. Strahlenther Onkol 2006;182:429-30.
• Krempien R, Niethammer A, Harms W, Debus J.: Use of bisphosphonates for bone metastases. Expert Rev Anticancer Ther
• Harms W, Krempien R, Grehn C, Schneeweiß A, Sohn C, Debus J.: Strahlentherapie lokoregionärer Mammakarzinomrezidive. JournalOnkologie 2005;1:14-16.
• Ryschich E, Jesnowski R, Ringel J, Harms W, Fabian OV, Saller R, Schrewe M, Engel A, Schmidt J, Lohr M.: Combined therapy of experimental pancreatic cancer with CYP2B1 producing cells: low-dose ifosfamide and local tumor irradiation. Int J Cancer 2005;113:649-53.
• Maksan SM, Schmidt E, Ryschich E, Harms W, Schmidt J.: Enhancement of leukocyte adhesion after percutaneous irradiation in rats with hepatocellular carcinoma. World J Gastroenterol
• Krempien R, Grehn C, Haag C, Straulino A, Hensley FW, Kotrikova B, Hofele C, Debus J, Harms W.: Feasibility report for retreatment of locally recurrent head and neck cancer by combined brachy-chemotherapy using frameless image guided 3D interstitial brachytherapy. Brachytherapy 2005;4:154-62.
• Harms W, Krempien R, Grehn C, Berns C, Hensley FW, Debus J.: Daytime pulsed dose rate brachytherapy as a new treatment option for previously irradiated patients with recurrent oesophageal cancer. British J Radiol 2005;78:236-41.
• Dietz A, Rudat V, Harms W, Jungehülsing M, Dollner R, Henze M.: Diagnostik mittels 18F-FDG-PET nach Larynxorganerhalt durch primäre Radiochemotherapie. HNO 2004;52:38-44.
• Krempien R, Heinemann V, Münter M, Harms W, Debus J.: Multimodale kurative /neoadjuvante Therapie beim Pankreaskarzinom. Onkologe 2004;10:1301-9.
• Krempien R, Hassfeld S, Kozak J, Tuemmler HP, Däuber S, Treiber M, Debus J, Harms W.: Frameless image guidance improves accuracy in three dimensional interstitial brachytherapy needle placement. Int J Radiat Oncol Biol Phys 2004;60:1645–51.
• Harms W, Krempien R, Grehn C, Hensley F, Berns C, Wannenmacher M.: Debus J. Rebestrahlung der Thoraxwand bei lokal rezidivierenden Mammakarzinomen. Zentralbl Gynäkol 2004;126:19-23.
• Ryschich E, Schmidt J, Loeffler T, Gebhard M, Harms W, Klar E.: Different radiogenic effects on microcirculation in healthy pancreas and in pancreatic carcinoma of the rat. Ann Surg 2003;237:515-21.
• Ryschich E, Harms W, Loeffler T, Eble M, Klar E, Schmidt J.: Radiation-induced leukocyte adhesion to endothelium in normal pancreas and in pancreatic carcinoma of the rat. Int J Cancer 2003;105:506-11.
• Krempien R, Huber P, Harms W, Treiber M, Wannenmacher W, Krempien B.: Combination of early bisphosphonate administration and irradiation enables improved remineralization and restabilization of osteolytic bone metastases in an animal tumor model. Cancer 2003;98:1318-24.
• Krempien R, Daeuber S, Hensley FW, Wannenmacher M, Harms W.: Image fusion of CT and MRI data enables improved target volume definition in 3D-brachytherapy treatment planning. Brachytherapy 2003;2(3):164-71.
• Kayhan N, Krempien R, Harms W, Wannenmacher M, Hagl S, Vahl CF.: Rechnerunterstützte Rekonstruktion von Herzkranzgefässen. Biomed Tech 47 Suppl 1 Pt 2002;2:930-2.
• Krempien RC, Schubert K, Zierhut D, Steckner MC, Treiber M, Harms W, Mende U, Latz D, Wannenmacher M, Wenz F.: Open low-field magnetic resonance imaging in radiation therapy treatment planning. Int J Radiat Oncol Biol Phys 2002;53:1350-60.
• Gagel B, Schramm O, Harms W, Mulhern A, Wenz F, van Kampen M, Wannenmacher M, Eble MJ.: The electronic portal imaging system Siemens Beamview Plus versus the conventional verifications films CEA-TVS and DuPont COL-7. A critical appraisal of visual image quality. Strahlenther Onkol 2002;178:446-52.
• Harms W, Peschke P, Weber KJ, Hensley FW, Wolber G, Debus J, Wannenmacher M.: Dose-dependent differential effects of low and pulsed dose-rate brachytherapy in a radioresistant syngeneic rat prostate tumor model. Int J Radiat Biol 2002;78:617-23.
• Thilmann C, Zabel A, Nill S, Rhein B, Hoess A, Haering P, Milker-Zabel S, Harms W, Schlegel W, Wannenmacher M, Debus J.: Intensity-modulated radiotherapy of the female breast. Med Dosim 2002;27:79-90.
• Schulz-Ertner D, Zierhut D, Mende U, Harms W, Branitzki P, Wannenmacher M.: The role of radiation therapy in the management of desmoid tumors. Strahlenther Onkol 2002;178:78-83.
• Krempien R, Daeuber S, Hoppe H, Treiber M, Harms W, Raczkowsky J, Brief J, Debus J, Woern H, Wannenmacher M.: Daily patient set-up control in radiation therapy by coded light projection. Stud Health Technol Inform 2002;85:237-239.
• Ryschich E, Schmidt J, Loeffler T, Gebhard M, Harms W, Klar E.: Unterschiedliche Effekte der Bestrahlung im gesunden Pankreas und im Pankreaskarzinom der Ratte. Chirurgisches Forum 2002;31:227-9.
• Harms W, Krempien R, Hensley FW, Berns C, Fritz P, Wannenmacher M.: 5-year results of pulsed dose rate brachytherapy applied as a boost after breast-conserving therapy in patients at high risk for local recurrence from breast cancer. Strahlenther Onkol 2002;178:607-14.
• Harms W, Becker HD, Krempien R, Wannenmacher M.: Contemporary role of modern brachytherapy techniques in the management of malignant thoracic tumors. Semin Surg Oncol 2001;20:57-65.
• Harms W, Krempien R, Hensley FW, Berns C, Wannenmacher M, Fritz P.: Results of chest wall reirradiation using pulsed-dose-rate (PDR) brachytherapy molds for breast cancer local recurrences. Int J Radiat Oncol Biol Phys 2001;49:205-10.
• Harms W, Latz D, Becker H, Gagel B, Herth F, Wannenmacher M.: Treatment of primary tracheal carcinoma. The role of external and endoluminal radiotherapy. Strahlenther Onkol 2000;176:22-7.
• Harms W, Schraube P, Becker H, Latz D, Herth F, Fritz P, Wannenmacher M.: Effect and toxicity of endoluminal high-dose-rate (HDR) brachytherapy in centrally located tumors of the upper respiratory tract. Strahlenther Onkol 2000;176:60-6.
• Fritz P, Hensley FW, Berns C, Harms W, Wannenmacher M.: Long-term results of pulsed irradiation of skin metastases from breast cancer. Effectiveness and sequelae. Strahlenther Onkol 2000;176:368-76.
• Krempien R, Grabowski HA, Harms W, Hensley FW, Hassfeld S, Mende U, Treiber M, Wannenmacher M. :Synthetic image modalities generated from matched CT and MRI data: A new approach for using MRI in brachytherapy. Lecture Notes in Computer Science 1999;1679:963-72.
• Harms W, Latz D, Becker H, Herth F, Schraube P, Krempien R, Wannenmacher M.: HDR-brachytherapy boost for residual tumor after external beam radiotherapy in patients with tracheal malignancies. Radiother Oncol 1999;52:251-5.
• Schwarz S, Schwab S, Harms W, Hacke W.: Systemic lymphoma in patients with the initial diagnosis of primary central nervous system lymphoma: a report of two cases. J Neurol

Buchbeiträge

• Harms W.: Pulse dose rate (PDR) Brachytherapie – Experimentelle und klinische Untersuchungen zur Effektivität und Toxizität. In: Strahlenschutz in Forschung und Praxis Band 48/49, Herausgeber Pirich C, Wolf H, Reiners Ch, Deutsche Gesellschaft für Medizinischen Strahlenschutz, S.23-25,2007.
• Harms W, Weber K.: Biological Aspects: Total dose and fractionation In: Partial breast irradiation with multicatheter brachytherapy, Eds: Strnad, Ott; 2006.
• Freund U, Harms W.: Mammakarzinom, In: Facharztbuch Strahlentherapie, Eds: Wannenmacher M, Debus J, Wenz F; Springer-Verlag, Berlin-Heidelberg-New-York,S.451-82,2006.
• Bahnsen J, Hänsgen G, Harms W, Ladner HA: Weibliches Becken, In: Facharztbuch Strahlentherapie, Eds: Wannenmacher M, Debus J, Wenz F; Springer-Verlag, Berlin-Heidelberg-New-York,S.623-56;2006.
• Krempien R, Daeuber S, Hoppe H, Schorr O, Wannenmacher M, Harms W. Projektorbasierte erweiterte Realität in der interstitiellen Brachytherapie. Informatik Aktuell 2003.
• Friess H, Haberkorn U, Harms W, Nawroth P, Raue F, Post S, Schilling T, Weber T, Wannenmacher M, Otto HF.: Schriftenreihe des Tumorzentrums Heidelberg/Mannheim: Das Schilddrüsenkarzinom. Empfehlungen für eine standardisierte Diagnostik, Therapie und Nachsorge. 3. vollständig überarbeitete Auflage 2003.
• Becker HD, Harms W, Herth F.: Photodynamische Therapie. In: Management des Lungenkarzinoms, Eds: Drings P, Wannenmacher M; Springer-Verlag, Berlin-Heidelberg-New York,S.303-307,2003.
• Harms W, Herth F, Becker HD.: Optionen und Resultate der endobronchialen Brachytherapie. In: Management des Lungenkarzinoms, Eds: Drings P, Wannenmacher M; Springer-Verlag, Berlin-Heidelberg-New York,S.299-303,2003.
• Debus J, Lohr F, Harms W.: Radiotherapie. In: Management des Lungenkarzinoms, Eds: Drings P, Wannenmacher M; Springer-Verlag, Berlin-Heidelberg-New York,S.259-267,2003.
• Becker HD, Harms W, Herth F.: Optionen und Resultate der endobronchialen Therapie. In: Management des Lungenkarzinoms, Eds: Drings P, Wannenmacher M; Springer-Verlag, Berlin-Heidelberg-New York,S.286-298,2003.
• Krempien R, Daeuber S, Hoppe H, Treiber M, Debus J, Harms W, Brief J, Raczkowsky J, Wörn H, Wannenmacher W.: Daily patient set-up in radiation therapy by structural light projection. In: H.U. Lemke, M.W. Vannier, K. Inamura, A.G. Farman (eds.): Proceedings of the 15th International Congress and Exhibition on Computer Assisted Radiology and Surgery (CARS 2001), Berlin, Elsevier Press,S.1094,2001.
• Krempien R, Grabowski HA, Harms W, Daeuber S, Hensley FW, Pernozzoli A, Brief J, Treiber M, Wannenmacher M.: Image fusion in radiotherapy. In: W. Schlegel, T. Bortfeld (eds.): The use of computers in radiation therapy. Proceedings of XIIIth ICCR, Heidelberg, May 22-25, Springer-Verlag, Berlin-Heidelberg-New-York,S.93-95,2000.
• Fritz P, Hensley FW, Berns C, Harms W, Wannenmacher M.: Pulsed irradiation of the human skin (effectiveness and sequelae). In Kongressband Deutsche Brachytherapiekonferenz 05.-07.03.1997 Lübeck. Eds: E. Richter, T. Feyerabend, M. Marx;S.200,1997.